Eckelman Brendan P.
CIK 0001766433
Chief Scientific Officer
Filings
9
Latest May 30, 2024
Issuers covered
2
Showing
9 of 9
Page 1
Track record
1 of 14 open-market trades scored (7% price coverage) - 13 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -13.3% | -13.3% | -13.3% | -13.3% |
| 90 days | 1 | 0% | -13.5% | -13.5% | -13.5% | -13.5% |
| 180 days | 1 | 0% | -18.8% | -18.8% | -18.8% | -18.8% |
| 365 days | 1 | 0% | -9.9% | -9.9% | -9.9% | -9.9% |
Issuers
Companies where Eckelman Brendan P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INBX | Inhibrx, Inc. | 8 | May 30, 2024 |
| INBX | Inhibrx Biosciences, Inc. | 1 | May 30, 2024 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|